Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Escalation Study of AL-39324 Suspension Versus Lucentis® for the Treatment of Exudative Age-Related Macular Degeneration

NCT00992563 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00992563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00992563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Escalation Study of AL-39324 Suspension Versus Lucentis® for the Treatment of Exudative Age-Related Macular Degeneration
Lead sponsor
Alcon Research
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
May 31, 2011
Enrollment
35 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration